ASND

Ascendis Pharma A Stock Analysis

AI Rating

Fair
  • Quality0/10
  • Growth↑ 9/10
  • Value↓ 1/10
Ascendis Pharma A sales and earnings growth
ASND Growth
Great
  • Revenue Y/Y↑ 132.18%
  • EPS Y/Y↑ 238.04%
  • FCF Y/Y↑ 120.46%
Ascendis Pharma A gross and profit margin trends
ASND Profitability
Good
  • Gross margin ↑ 89.00%
  • EPS margin↑ 57.30%
  • ROIC 5Y↓ -39.10%
Ascendis Pharma A net debt vs free cash flow
ASND Risk
Good
  • Debt / Equity↓ 1.8
  • Debt / FCF↑ 7.2
  • Interest coverage↓ 0.3

Ascendis Pharma A stock is less volatile than the overall market, so it's low risk. We give it a Good risk rating.

↗ More Biotechnology stocks